Sinfonia Biotherapeutics is developing precision therapies for genetically-defined dementia and related neurodegenerative diseases, such as Frontotemporal dementia and Parkinson’s disease. There is a huge unmet medical need for effective treatments for these devastating illnesses. Our developmental biologic therapies are delivered directly to affected brain tissues using our clinical-stage bioreactor to halt disease progression.